Regulatory Approval of Ferric Carboxy Maltose Injection 50mg/ml: A Comparison Across South Africa, Singapore and Saudi Arabia

Abstract

The regulatory approval Procedure for iron formulation, like Ferric Carboxy Maltose injection 50mg/ml , differs among international health authorities because to variation in evaluation schedules, dossier requirements, and reliance mechanisms The registration process and legal frameworks controlling the approval of ferric carboxy maltose in South Africa, Singapore and Saudi Arabia are compared in this paper   The Common Technical Document Format  used in  South Africa by the  South Africa Regulatory Authority If the product  approved by strict regulatory bodies, it may use a reliance approach through an abridge or verified review for items registered by reference agencies , Singapore's through an abridged or verified review for items by reference agencies Singapore's Health Sciences Authority (HSA) allows submission thorough verification or abridged evaluation Route, allowing the faster access. Saudi Regulatory Authority permit dependence FDA or EMA approvals via the Shortened registration procedure and adheres to GCC-CTD Framework the Comparative analysis emphazies regional variation in data expectations, stability circumstances, and labelling requirements while highlighting the growing global harmonisation through dependency models. Improving regulatory convergence and reliance frameworks can improve the patient access to high-quality injectable iron supplements and maximize review efficiency.

Conclusion:  South African Regulatory Authority, Health Science Authority and Saudi Food Drug Regulatory Authority show differences in Timelines, dossier formats, and local Requirements for Ferric Carboxy Maltose Injection approval. However, all three are used Reliance Pathways based on approval of reference agencies Despite Regional variation this sifts supports global harmonization Strengthening Reliance Models can improve efficiency and faster patient access.